Adult Giant Cell Glioblastoma Completed Phase 2 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039494Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain TumorsTreatment